HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sher, I. Articles by Ron, D. Search for Related Content PubMed PubMed Citation Articles by Sher, I. Articles by Ron, D. Social Bookmarking                      What's this?

J Biol Chem, Vol. 274, Issue 49, 35016-35022, December 3, 1999

Mutations Uncouple Human Fibroblast Growth Factor (FGF)-7 Biological Activity and Receptor Binding and Support Broad Specificity in the Secondary Receptor Binding Site of FGFs

Ifat Sher, Alexander Weizman, Sharon Lubinsky-Mink, Tamar Lang, Noam Adir^§, Dietmar Schomburg^¶, and Dina Ron

From the  Department of Biology and ^§ Department of Chemistry, Technion-Israel Institute of Technology, Haifa 32000, Israel and the ^¶ Institut fuer Biochemie, Universitat zu Koeln, Zuelpicher Strasse 47, 50674 Koeln, Germany

The fibroblast growth factor (FGF) family plays a key role in a multitude of physiological and pathological processes. The activities of FGFs are mediated by a family of tyrosine kinase receptors, designated FGFRs. The mechanism by which FGFs induce receptor activation is controversial. Despite their structural similarity, FGFs display distinct receptor binding characteristics and cell type specificity. Previous studies with FGF-2 identified a low affinity receptor binding site that is located within a loop connecting its 9th and 10th -strands. The corresponding residues in the other family members are highly variable, and it was proposed that the variability might confer on FGFs unique receptor binding characteristics. We studied the role of this loop in FGF-7 by both site-directed mutagenesis and loop replacement. Unlike the other members of the FGF family, FGF-7 recognizes only one FGFR isoform and is, therefore, ideal for studies of how the specificity in the FGF-FGFR interaction is conferred at the structural level. Point mutations in the loop of FGF-7 did not change receptor binding affinity but resulted in reduced mitogenic potency and reduced ability to induce receptor-mediated phosphorylation events. These results suggest that the loop of FGF-7 fulfills the role of low affinity binding site required for receptor activation. The observation that it is possible to uncouple FGF-7 receptor binding and biological activity favors a bivalent model for FGFR dimerization, and it may be clinically relevant to the design of FGF-7 antagonists. Reciprocal loop replacement between FGF-7 and FGF-2 had no effect on their known receptor binding affinities nor did it alter their known specificity in eliciting a mitogenic response. In conclusion, these results suggest that, despite the diversity in the loop structure of FGF-2 and FGF-7, the loop has a similar function in both growth factors.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				R. Goetz, A. Beenken, O. A. Ibrahimi, J. Kalinina, S. K. Olsen, A. V. Eliseenkova, C. Xu, T. A. Neubert, F. Zhang, R. J. Linhardt, et al. Molecular Insights into the Klotho-Dependent, Endocrine Mode of Action of Fibroblast Growth Factor 19 Subfamily Members Mol. Cell. Biol., May 1, 2007; 27(9): 3417 - 3428. [Abstract] [Full Text] [PDF]

				I. Sher, S. Zisman-Rozen, L. Eliahu, J. M. Whitelock, N. Maas-Szabowski, Y. Yamada, D. Breitkreutz, N. E. Fusenig, E. Arikawa-Hirasawa, R. V. Iozzo, et al. Targeting Perlecan in Human Keratinocytes Reveals Novel Roles for Perlecan in Epidermal Formation J. Biol. Chem., February 24, 2006; 281(8): 5178 - 5187. [Abstract] [Full Text] [PDF]

				D. C. West, C. G. Rees, L. Duchesne, S. J. Patey, C. J. Terry, J. E. Turnbull, M. Delehedde, C. W. Heegaard, F. Allain, C. Vanpouille, et al. Interactions of Multiple Heparin Binding Growth Factors with Neuropilin-1 and Potentiation of the Activity of Fibroblast Growth Factor-2 J. Biol. Chem., April 8, 2005; 280(14): 13457 - 13464. [Abstract] [Full Text] [PDF]

				E. Preger, I. Ziv, A. Shabtay, I. Sher, M. Tsang, I. B. Dawid, Y. Altuvia, and D. Ron Alternative splicing generates an isoform of the human Sef gene with altered subcellular localization and specificity PNAS, February 3, 2004; 101(5): 1229 - 1234. [Abstract] [Full Text] [PDF]

				B. Berman, O. Ostrovsky, M. Shlissel, T. Lang, D. Regan, I. Vlodavsky, R. Ishai-Michaeli, and D. Ron Similarities and Differences between the Effects of Heparin and Glypican-1 on the Bioactivity of Acidic Fibroblast Growth Factor and the Keratinocyte Growth Factor J. Biol. Chem., December 17, 1999; 274(51): 36132 - 36138. [Abstract] [Full Text] [PDF]

				I. Sher, T. Lang, S. Lubinsky-Mink, J. Kuhn, N. Adir, S. Chatterjee, D. Schomburg, and D. Ron Identification of Residues Important Both for Primary Receptor Binding and Specificity in Fibroblast Growth Factor-7 J. Biol. Chem., November 3, 2000; 275(45): 34881 - 34886. [Abstract] [Full Text] [PDF]

				O. Ostrovsky, B. Berman, J. Gallagher, B. Mulloy, D. G. Fernig, M. Delehedde, and D. Ron Differential Effects of Heparin Saccharides on the Formation of Specific Fibroblast Growth Factor (FGF) and FGF Receptor Complexes J. Biol. Chem., January 18, 2002; 277(4): 2444 - 2453. [Abstract] [Full Text] [PDF]